logo
Product categories

EbookNice.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link.  https://ebooknice.com/page/post?id=faq


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookNice Team

(Ebook) Anticancer Drug Development Guide (Cancer Drug Discovery and Development) by Beverly Teicher, Paul Andrews ISBN 9781588292285, 9781592597390, 1588292282, 1592597394

  • SKU: EBN-1709624
Zoomable Image
$ 32 $ 40 (-20%)

Status:

Available

5.0

7 reviews
Instant download (eBook) Anticancer Drug Development Guide (Cancer Drug Discovery and Development) after payment.
Authors:Beverly Teicher, Paul Andrews
Pages:430 pages.
Year:2004
Editon:1
Publisher:Humana
Language:english
File Size:4.23 MB
Format:pdf
ISBNS:9781588292285, 9781592597390, 1588292282, 1592597394
Categories: Ebooks

Product desciption

(Ebook) Anticancer Drug Development Guide (Cancer Drug Discovery and Development) by Beverly Teicher, Paul Andrews ISBN 9781588292285, 9781592597390, 1588292282, 1592597394

This thoroughly updated and expanded second edition of Beverly Teicher's widely used classic survey provides a step-by-step guide to anticancer drug development from initial design through FDA approval. The authors have included new material on the use of high throughput screening in industry, on specialized in vitro/in vivo procedures employed by the National Cancer Institute (NCI) in preclinical drug evaluations, and on nonclinical testing to support both human clinical trials, as well as trials of biologic oncology products. The chapters on phase I, II, and III clinical trials and on novel phase II clinical trial designs for targeted therapies have been significantly updated, along with those on cancer drug development in Europe, working with the NCI, and the FDA's role in cancer drug development and setting requirements for approval.
*Free conversion of into popular formats such as PDF, DOCX, DOC, AZW, EPUB, and MOBI after payment.

Related Products